NAOKO OKADA

Associate professor

Nihon Pharmaceutical University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Naoko Okada is an Associate Professor at Nihon Pharmaceutical University in Japan. Her research focuses on ocular health, particularly the roles of aquaporins in lacrimal gland cells and the development of mouse models for atopic keratoconjunctivitis. Recent articles include studies on prostaglandin E 2 levels in allergic conjunctivitis and the effects of various pharmacological interventions on conjunctival cells.

Articles (9)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Hiroyuki Yazu

Tsurumi University School of Dental Medicine

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

NAOKO OKADA

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Aquaporins 8 and 9 as Possible Markers for Adult Murine Lacrimal Gland Cells.

The FADS mouse: A novel mouse model of atopic keratoconjunctivitis.

The FADS mouse: A novel mouse model of atopic keratoconjunctivitis

Elevated levels of prostaglandin E<sub>2</sub> in the tears of patients with severe allergic conjunctivitis and primary cultured conjunctival cells are suppressed by ketotifen and dexamethasone.

Elevated levels of prostaglandin E-2 in the tears of patients with severe allergic conjunctivitis and primary cultured conjunctival cells are suppressed by ketotifen and dexamethasone

The Effect of Cytokine-Stimulation and Pharmacologic Intervention on PGE2 Production in Primary Human Conjunctival and Corneal Cells

Effects of Docosahexaenoic Acid on Chemokine Expression in Human Conjunctival Fibroblasts

Conjunctival Injection Reduction in Patients with Atopic Keratoconjunctivitis Due to Synergic Effect of Bovine Enteric-Coated Lactoferrin in 0.1% Tacrolimus Ophthalmic Suspension.

Conjunctival Injection Reduction in Patients with Atopic Keratoconjunctivitis Due to Synergic Effect of Bovine Enteric-Coated Lactoferrin in 0.1% Tacrolimus Ophthalmic Suspension

Collaborators (1)

Hiroyuki Yazu

Make your next move.